A committee of subject matter experts established by the Comptroller General of Drugs of India (DCGI) to review COVID-19 vaccine proposals, recommended an “interim efficacy analysis for Covaxin.” The vaccine was developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR). The expert committee asked a …
Read More »
The firm, in its request submitted to the drug regulator, has requested permission to import the vaccine for sale and distribution in the country. Pfizer India has become the first pharmaceutical company to apply to the Controller General of Drugs of India (DCGI) for an emergency use authorization for its …
Read More »
NEW DELHI: Hyderabad-based leading vaccine Bharat Biotech has announced that its Covid-19 vaccine candidate, Covaxin, during its tests on animal rhesus macaques, has developed a “robust immune response” to the highly infectious coronavirus, “preventing infections and diseases in primates after large amounts of exposure to the live SARS-CoV-2 virus ”. …
Read More »
The whole world is waiting with great anticipation for a ‘safe and effective’ vaccine against the new coronavirus. Currently, three candidate vaccines are in different stages of testing in India. Two homegrown candidate vaccines, Covaxin from Bharat Biotech and ZyCoV-D from Zydus Cadila have already started the phase II clinical …
Read More »